Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Zummer

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Seminars in Arthritis and Rheumatism|May 19, 2012
Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohortAlan M Borowoy, Janet E Pope, Earl Silverman, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 22, 2016
Review of Current Workforce for Rheumatology in the Countries of the Americas 2012-2015John D Reveille, Roberto Muñoz, Enrique Soriano, et al.
Arthritis Care & Research|April 26, 2016
Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of LupusAngela George, Andrew Wong-Pack, Christine A Peschken, et al.
The Journal of Rheumatology|April 17, 2009
The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohortChristine A Peschken, Steven J Katz, Earl Silverman, et al.
The Journal of Rheumatology|November 17, 2010
Medication use in systemic lupus erythematosusSasha Bernatsky, Christine Peschken, Paul R Fortin, et al.
The Journal of Rheumatology|September 17, 2011
Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugsVivian P Bykerk, Pooneh Akhavan, Glen S Hazlewood, et al.
Rheumatology (Oxford, England)|February 27, 2019
A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus CohortHyein Kim, Deborah M Levy, Earl D Silverman, et al.
BMJ Open|April 7, 2016
Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitisProton Rahman, Denis Choquette, William G Bensen, et al.
Arthritis and Rheumatism|March 4, 2008
The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritisMurray Baron, Orit Schieir, Marie Hudson, et al.
The Journal of Rheumatology|June 19, 2012
Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safetyClaire Bombardier, Glen S Hazlewood, Pooneh Akhavan, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Seminars in Arthritis and Rheumatism|May 19, 2012
Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohortAlan M Borowoy, Janet E Pope, Earl Silverman, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 22, 2016
Review of Current Workforce for Rheumatology in the Countries of the Americas 2012-2015John D Reveille, Roberto Muñoz, Enrique Soriano, et al.
Arthritis Care & Research|April 26, 2016
Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of LupusAngela George, Andrew Wong-Pack, Christine A Peschken, et al.
The Journal of Rheumatology|April 17, 2009
The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohortChristine A Peschken, Steven J Katz, Earl Silverman, et al.
The Journal of Rheumatology|November 17, 2010
Medication use in systemic lupus erythematosusSasha Bernatsky, Christine Peschken, Paul R Fortin, et al.
The Journal of Rheumatology|September 17, 2011
Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugsVivian P Bykerk, Pooneh Akhavan, Glen S Hazlewood, et al.
Rheumatology (Oxford, England)|February 27, 2019
A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus CohortHyein Kim, Deborah M Levy, Earl D Silverman, et al.
BMJ Open|April 7, 2016
Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitisProton Rahman, Denis Choquette, William G Bensen, et al.
Arthritis and Rheumatism|March 4, 2008
The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritisMurray Baron, Orit Schieir, Marie Hudson, et al.
The Journal of Rheumatology|June 19, 2012
Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safetyClaire Bombardier, Glen S Hazlewood, Pooneh Akhavan, et al.
Pageof 5